Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Verras
AddedFeb 18, 2024
UpdatedJun 18, 2026
Verras

Verras

Pre-Seed

Verras offers patented data analytics solutions for healthcare, uniquely addressing Medicare recipients' needs in the US.

HQ
Las Vegas, NV, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded to revolutionize healthcare data analytics, Verras focuses on providing transparent and patented analytic solutions tailored for the healthcare industry. Their core mission is to harness data intelligently to enhance healthcare services and value. Verras offers several proprietary tools, including the Acuity Index Method™ (AIM), Verras Sherlock™, Verras Watson™, Medical Value Index™ (MVI), and Physician Scorecard™, which are designed to measure resource consumption and clinical variation. Their market focus is primarily on payers, physicians, and hospitals in the United States, particularly addressing the needs of Medicare recipients.

Notable figures affiliated with Verras include its leadership team, comprised of experts in healthcare analytics and data science. The company has attracted significant interest from investors who recognize the potential of their patented solutions to transform healthcare delivery. Key achievements include the successful implementation of their tools in various healthcare settings, leading to improved efficiency and patient outcomes. Overall, Verras has made a substantial impact by enabling healthcare providers to make data-driven decisions that enhance care quality and operational efficiency.

Verras - Similar Companies

Versium logo

Versium

versium.com

VisiQuate logo

VisiQuate

visiquate.com

Verato logo

Verato

verato.com

Verana Health logo

Verana Health

veranahealth.com

Verisk Analytics logo

Verisk Analytics

verisk.com

Ilerasoft logo

Ilerasoft

Health Data Analytics Institute logo

Health Data Analytics Institute

hda-institute.com

Videra Health logo

Videra Health

viderahealth.com

Versalytix logo

Versalytix

versalytix.com

BioVeras logo

BioVeras

Veda Data Solutions logo

Veda Data Solutions

vedadata.com

Qualmetrix logo

Qualmetrix

qualmetrix.com

Vero Analytics logo

Vero Analytics

Ambient Clinical Analytics logo

Ambient Clinical Analytics

DaVincian Healthcare logo

DaVincian Healthcare

Verras - Quick Facts

Who are Verras' competitors?

Companies similar to Verras include Versium, VisiQuate, Verato and Verana Health.

When was Verras founded?

Verras was founded in 2021.

Where is Verras' headquarters located?

Verras' headquarters is located in Las Vegas, NV, US.

When was Verras' last funding round?

Verras' most recent funding round was for $250k (USD) in October 2021.

How much has Verras raised to-date?

As of Oct 1, 2021, Verras has raised a total of $250k (USD).

How many employees does Verras have?

Verras has 4 employees as of Feb 4, 2024.

Verras - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Data Analytics
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8060Hospitals